Your browser doesn't support javascript.
loading
Long-term cardiovascular outcomes in a population-based multicentric cohort of northern Portugal: Validation of the ESC/EAS prognostic risk classification.
Gavina, Cristina; Seabra Carvalho, Daniel; Afonso-Silva, Marta; Brandão Abreu, Daniela; Canelas-Pais, Mariana; Taveira-Gomes, Tiago; Araújo, Francisco.
Afiliação
  • Gavina C; Department of Medicine, Faculty of Medicine, University of Porto, Porto, Portugal; Hospital Pedro Hispano - Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal.
  • Seabra Carvalho D; Hospital Pedro Hispano - Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal.
  • Afonso-Silva M; Health Economics & Outcomes Research / Real-world evidence, Novartis Farma - Produtos Farmacêuticos SA, Porto Salvo, Portugal.
  • Brandão Abreu D; Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; MTG Research and Development Lab, Porto, Portugal.
  • Canelas-Pais M; MTG Research and Development Lab, Porto, Portugal; Department of Community Medicine, Health Information and Decision, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Taveira-Gomes T; MTG Research and Development Lab, Porto, Portugal; Department of Community Medicine, Health Information and Decision, Faculty of Medicine, University of Porto, Porto, Portugal; Faculty of Health Sciences, Fernando Pessoa University, Porto, Portugal. Electronic address: tiago.taveira@med.up.pt.
  • Araújo F; Departamento de Medicina Interna, Hospital Lusíadas, Lisboa, Portugal.
J Clin Lipidol ; 18(4): e562-e571, 2024.
Article em En | MEDLINE | ID: mdl-38908967
ABSTRACT

BACKGROUND:

Cardiovascular (CV) risk scores identify individuals at higher long-term risk of CV events that may benefit from more aggressive preventive interventions.

OBJECTIVE:

To assess the association of CV-risk categories and criteria with long-term CV events.

METHODS:

Observational cohort study between 2000-2019 on patients aged 40-80 years, followed by 14 primary care centers assisted by 1 hospital in Portugal. Follow-up began when electronic health records data allowed for CV-risk classification and dynamic reassessment per 2019 ESC/EAS Guidelines. Inclusion criteria required at least one appointment with a primary care physician within three years before follow-up initiation. We assessed the 10-year adjusted hazard-ratio of combined CV death and non-fatal atherosclerotic cardiovascular disease (ASCVD) hospitalization, across SCORE risk categories and criteria, using Cox proportional hazards models adjusted for sex, age, competing comorbidities, and medication.

RESULTS:

The study included 161 681 observations from 87 035 unique patients. During the observation period, 71 787 patients were classified as low/moderate, 51 476 as high and 38 418 as very-high CV-risk categories. In the very-high group, prevalent comorbidities were hypertension (69%), hypercholesterolemia (69%) and type 2 diabetes (61%), and 13% were hospitalized for ASCVD. The adjusted 10-year hazard ratio of the composite of CV death or ASCVD hospitalization was 2.10 (95% CI 1.91-2.32) for high-risk and 3.56 (95% CI 3.21-3.96) for very-high-risk patients (low-risk as reference).

CONCLUSION:

Our study reinforces the prognostic relevance of CV-risk stratification for long-term prediction of CV death and ASCVD hospitalization in an unselected cohort, independently of sex, age, competing comorbidities and medication.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article